Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA2D1 | P54289 | 20/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5009952 | 0.88 | CACNA2D1 (0.76) | CACNA2D1 | |
| SCHEMBL5004705 | 0.87 | CACNA2D1 (0.77) | CACNA2D1 | |
| SCHEMBL5005683 | 0.85 | CACNA2D1 (1.00) | CACNA2D1 | |
| SCHEMBL5001479 | 0.84 | CACNA2D1 (0.76) | CACNA2D1 | |
| SCHEMBL5004900 | 0.83 | CACNA2D1 (0.79) | CACNA2D1 | |
| SCHEMBL5007944 | 0.83 | CACNA2D1 (0.73) | CACNA2D1 | |
| SCHEMBL5005177 | 0.80 | CACNA2D1 (0.78) | CACNA2D1 | |
| SCHEMBL5005399 | 0.79 | CACNA2D1 (0.78) | CACNA2D1 | |
| SCHEMBL5004720 | 0.79 | CACNA2D1 (0.70) | CACNA2D1 | |
| SCHEMBL5009750 | 0.79 | CACNA2D1 (0.53) | CACNA2D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7465730-B2 | Treatment of neuropathic pain with 6H-pyrrolo[3,4-d]pyridazine compounds | MERCK & CO. INC. (US) | 2008-12-16 | — | — | US | disclosed |
| US-7465730-B2 | Treatment of neuropathic pain with 6H-pyrrolo[3,4-d]pyridazine compounds | MERCK & CO. INC. (US) | 2008-12-16 | — | — | US | disclosed |